Rare diseases
Investigational molecules
Locations
117 Kendrick Street Suite 500, 02494-2730, United States
Verastem Inc. supports clinical research in non-small cell lung cancer with a focus on targeted treatment strategies for tumors carrying G12C alterations. The sponsor’s studies examine combinations centered on avutometinib and sotorasib in patients with advanced lung cancer.
The research activity reflects sustained interest in molecularly defined thoracic oncology and treatment options for KRAS G12C-mutant disease.
Verastem Inc. runs clinical trials in conditions such as Ovarian cancer, Malignant mast cell neoplasm, Ovarian cancer recurrent, Non-small cell lung cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
France
BelgiumBelgiumBelgiumBelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
